Cited by 24Osteoarthritis Treatment and MechanismsNatural Compounds in Disease TreatmentBone Metabolism and Diseases

Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARγ to inhibit NF‐κB signalling pathway

Open access
Lu, Jiansen, Guan, Hong, Wu, Dan, Hu, Zhiqiang, Zhang, Hongbo, Jiang, Huaji, Yu, Jingyao, Zeng, Ke +5 more·2021·Journal of Cellular and Molecular Medicine

Abstract

Synovial macrophage polarization and inflammation are essential for osteoarthritis (OA) development, yet the molecular mechanisms and regulation responsible for the pathogenesis are still poorly understood. Here, we report that pseudolaric acid B (PAB) attenuated articular cartilage degeneration and synovitis during OA. PAB, a diterpene acid, specifically inhibited NF‐κB signalling and reduced the production of pro‐inflammatory cytokines, which further decreased M1 polarization and vessel formation. We further provide in vivo and in vitro evidences that PAB suppressed NF‐κB signalling by stabilizing PPARγ. Using PPARγ antagonist could abolish anti‐inflammatory effect of PAB and rescue the activation of NF‐κB signalling during OA. Our findings identify a previously unrecognized role of PAB in the regulation of OA and provide mechanisms by which PAB regulates NF‐κB signalling through PPARγ, which further suggest targeting synovial inflammation or inhibiting vessel formation at early stage could be an effective preventive strategy for OA.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jcmm.16670

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 55

  1. [1]Bijlsma JWJ, Berenbaum F, Lafeber FPJG. Osteoarthritis: an update with relevance for clinical practice. Lancet. 2011; 377(9783): 2115‐ 2126. 10.1016/s0140-6736(11)60243-2 21684382 · DOI
  2. [2]Glyn‐Jones S, Palmer AJ, Agricola R, et al. Osteoarthritis. Lancet. 2015; 386(9991): 376‐ 387. 10.1016/S0140-6736(14)60802-3 25748615 · DOI · Paper page
  3. [3]Jones G, Winzenberg T. Osteoarthritis: a new short‐term treatment option? The Lancet. 2019; 394(10213): 1967‐ 1968. 10.1016/s0140-6736(19)32729-1. 31727408 · DOI
  4. [4]Hunter DJ, Bierma‐Zeinstra S. Osteoarthritis. Lancet. 2019; 393(10182): 1745‐ 1759. 10.1016/s0140-6736(19)30417-9 31034380 · DOI
  5. [5]Robinson WH, Lepus CM, Wang Q, et al. Low‐grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016; 12(10): 580‐ 592. 10.1038/nrrheum.2016.136. 27539668 PMC5500215 · DOI
  6. [6]Zhao Z, Dai XS, Wang ZY, Bao ZQ, Guan JZ. MicroRNA‐26a reduces synovial inflammation and cartilage injury in osteoarthritis of knee joints through impairing the NF‐kappaB signaling pathway. Biosci Rep. 2019; 39(4). 10.1042/BSR20182025 PMC6454017 30872407 · DOI
  7. [7]Atukorala I, Kwoh CK, Guermazi A, et al. Synovitis in knee osteoarthritis: a precursor of disease? Ann Rheum Dis. 2016; 75(2): 390‐ 395. 10.1136/annrheumdis-2014-205894 25488799 PMC4916836 · DOI
  8. [8]Krasnokutsky S, Belitskaya‐Levy I, Bencardino J, et al. Quantitative magnetic resonance imaging evidence of synovial proliferation is associated with radiographic severity of knee osteoarthritis. Arthritis Rheum. 2011; 63(10): 2983‐ 2991. 10.1002/art.30471 21647860 PMC3183134 · DOI
  9. [9]Barreto G, Senturk B, Colombo L, et al. Lumican is upregulated in osteoarthritis and contributes to TLR4‐induced pro‐inflammatory activation of cartilage degradation and macrophage polarization. Osteoarthritis Cartilage. 2020; 28(1): 92‐ 101. 10.1016/j.joca.2019.10.011 31715293 · DOI
  10. [10]Scanzello CR, Plaas A, Crow MK. Innate immune system activation in osteoarthritis: is osteoarthritis a chronic wound? Curr Opin Rheumatol. 2008; 20(5): 565‐ 572. 10.1097/BOR.0b013e32830aba34. 18698179 · DOI
  11. [11]Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010; 140(6): 805‐ 820. 10.1016/j.cell.2010.01.022 20303872 · DOI · Paper page
  12. [12]Sokolove J, Lepus CM. Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations. Ther Adv Musculoskelet Dis. 2013; 5(2): 77‐ 94. 10.1177/1759720x12467868. 23641259 PMC3638313 · DOI · Paper page
  13. [13]Shapouri‐Moghaddam A, Mohammadian S, Vazini H, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018; 233(9): 6425‐ 6440. 10.1002/jcp.26429 PMC13482560 29319160 · DOI · Paper page
  14. [14]Schulert GS, Fall N, Harley JB, et al. Monocyte MicroRNA expression in active systemic juvenile idiopathic arthritis implicates microRNA‐125a‐5p in polarized monocyte phenotypes. Arthritis Rheumatol. 2016; 68(9): 2300‐ 2313. 10.1002/art.39694 27014994 PMC5001902 · DOI
  15. [15]Lopa S, Leijs M, Moretti M, Lubberts E, van Osch G, Bastiaansen‐Jenniskens YM. Arthritic and non‐arthritic synovial fluids modulate IL10 and IL1RA gene expression in differentially activated primary human monocytes. Osteoarthr Cartil. 2015; 23(11): 1853‐ 1857. 10.1016/j.joca.2015.06.003 26521731 · DOI
  16. [16]Wen C, Chen J, Zhang D, et al. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5‐fluorouracil‐sensitive and ‐resistant colorectal cancer cells. Cancer Lett. 2016; 383(2): 295‐ 308. 10.1016/j.canlet.2016.09.007 27713084 · DOI
  17. [17]Yin Z, Cai H, Wang Z, Jiang Y. Pseudolaric acid B inhibits proliferation, invasion, and angiogenesis in esophageal squamous cell carcinoma through regulating CD147. Drug Des Dev Therapy. 2020; 14: 4561‐ 4573. 10.2147/dddt.S269915 PMC7605399 33149553 · DOI
  18. [18]Wang D, Xin Y, Tian Y, Li W, Sun D, Yang Y. Pseudolaric acid B inhibits gastric cancer cell metastasis in vitro and in haematogenous dissemination model through PI3K/AKT, ERK1/2 and mitochondria‐mediated apoptosis pathways. Exp Cell Res. 2017; 352(1): 34‐ 44. 10.1016/j.yexcr.2017.01.012 28132880 · DOI
  19. [19]Li T, Wang W, Li YX, et al. Pseudolaric acid B attenuates atherosclerosis progression and inflammation by suppressing PPARgamma‐mediated NF‐kappaB activation. Int Immunopharmacol. 2018; 59: 76‐ 85. 10.1016/j.intimp.2018.03.041 29631101 · DOI
  20. [20]Li T, Chen H, Yang Z, et al. Topical application of Pseudolaric acid B improve DNFB‐induced contact hypersensitivity via regulating the balance of Th1/Th17/Treg cell subsets. Eur J Pharm Sci. 2012; 45(5): 668‐ 676. 10.1016/j.ejps.2012.01.005 22266211 · DOI
  21. [21]Li T, Wang W, Zhao JH, Zhou X, Li YM, Chen H. Pseudolaric acid B inhibits T‐cell mediated immune response in vivo via p38MAPK signal cascades and PPARgamma activation. Life Sci. 2015; 121: 88‐ 96. 10.1016/j.lfs.2014.11.020 25497712 · DOI
  22. [22]Tong YG, Zhang XW, Geng MY, et al. Pseudolarix acid B, a new tubulin‐binding agent, inhibits angiogenesis by interacting with a novel binding site on tubulin. Mol Pharmacol. 2006; 69(4): 1226‐ 1233. 10.1124/mol.105.020537 16424078 · DOI
  23. [23]Li MH, Miao ZH, Tan WF, et al. Pseudolaric acid B inhibits angiogenesis and reduces hypoxia‐inducible factor 1alpha by promoting proteasome‐mediated degradation. Clin Cancer Res. 2004; 10(24): 8266‐ 8274. 10.1158/1078-0432.CCR-04-0951 15623602 · DOI
  24. [24]Zhu M, Deng G, Tan P, et al. Beclin 2 negatively regulates innate immune signaling and tumor development. Journal of Clinical Investigation. 2020; 130(10): 5349‐ 5369. 10.1172/jci133283 PMC7524487 32865519 · DOI
  25. [25]Tan P, He L, Xing C, et al. Myeloid loss of Beclin 1 promotes PD‐L1hi precursor B cell lymphoma development. J Clin Invest. 2019; 129(12): 5261‐ 5277. 10.1172/JCI127721 31503548 PMC6877338 · DOI
  26. [26]Zhang H, Lin C, Zeng C, et al. Synovial macrophage M1 polarisation exacerbates experimental osteoarthritis partially through R‐spondin‐2. Ann Rheum Dis.. 2018; 77(10): 1524‐ 1534. 10.1136/annrheumdis-2018-213450 29991473 · DOI
  27. [27]Zhang H, Wang H, Zeng C, et al. mTORC1 activation downregulates FGFR3 and PTH/PTHrP receptor in articular chondrocytes to initiate osteoarthritis. Osteoarthr Cartil. 2017; 25(6): 952‐ 963. 10.1016/j.joca.2016.12.024 28043938 · DOI
  28. [28]Krenn V, Morawietz L, Burmester GR, et al. Synovitis score: discrimination between chronic low‐grade and high‐grade synovitis. Histopathology. 2006; 49(4): 358‐ 364. 10.1111/j.1365-2559.2006.02508.x 16978198 · DOI
  29. [29]de Munter W, Geven EJ, Blom AB, et al. Synovial macrophages promote TGF‐beta signaling and protect against influx of S100A8/S100A9‐producing cells after intra‐articular injections of oxidized low‐density lipoproteins. Osteoarthritis Cartilage. 2017; 25(1): 118‐ 127. 10.1016/j.joca.2016.07.020 27514996 · DOI
  30. [30]Guo H, Callaway JB, Ting JP. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med. 2015; 21(7): 677‐ 687. 10.1038/nm.3893 26121197 PMC4519035 · DOI · Paper page
  31. [31]Pesesse L, Sanchez C, Henrotin Y. Osteochondral plate angiogenesis: a new treatment target in osteoarthritis. Joint Bone Spine. 2011; 78(2): 144‐ 149. 10.1016/j.jbspin.2010.07.001 20851653 · DOI
  32. [33]Lu J, Zhang H, Cai D, et al. Positive‐feedback regulation of subchondral H‐type vessel formation by chondrocyte promotes osteoarthritis development in mice. J Bone Miner Res. 33(5): 909‐ 920. 29329496
  33. [34]Wen ZH, Su YC, Lai PL, et al. Critical role of arachidonic acid‐activated mTOR signaling in breast carcinogenesis and angiogenesis. Oncogene. 2013; 32(2): 160‐ 170. 10.1038/onc.2012.47. 22349822 · DOI
  34. [35]Benito MJ, Veale DJ, FitzGerald O, van den Berg WB, Bresnihan B. Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis. 2005; 64(9): 1263‐ 1267. 10.1136/ard.2004.025270 15731292 PMC1755629 · DOI
  35. [36]Korbecki J, Bobinski R, Dutka M. Self‐regulation of the inflammatory response by peroxisome proliferator‐activated receptors. Inflamm Res. 2019; 68(6): 443‐ 458. 10.1007/s00011-019-01231-1 30927048 PMC6517359 · DOI · Paper page
  36. [37]Wang H, Zhang H, Fan K, et al. Frugoside delays osteoarthritis progression via inhibiting miR‐155‐modulated synovial macrophage M1 polarisation. Rheumatology (Oxford). 2021. 10.1093/rheumatology/keab018 33493345 · DOI
  37. [38]Mendez ME, Sebastian A, Murugesh DK, et al. LPS‐Induced inflammation prior to injury exacerbates the development of post‐traumatic osteoarthritis in mice. J Bone Miner Res. 2020; 35(11): 2229‐ 2241. 10.1002/jbmr.4117 32564401 PMC7689775 · DOI
  38. [39]Gao Y, Wang S, He L, Wang C, Yang L. Alpinetin protects chondrocytes and exhibits anti‐inflammatory effects via the NF‐κB/ERK pathway for alleviating osteoarthritis. Inflammation. 2020; 43(5): 1742‐ 1750. 10.1007/s10753-020-01248-3 32474881 · DOI
  39. [40]Wang Z, Huang J, Zhou S, et al. Anemonin attenuates osteoarthritis progression through inhibiting the activation of IL‐1β/NF‐κB pathway. J Cell Mol Med. 2017; 21(12): 3231‐ 3243. 10.1111/jcmm.13227 28643466 PMC5706500 · DOI
  40. [41]Chu J, Yan B, Zhang J, et al. Casticin attenuates osteoarthritis‐related cartilage degeneration by inhibiting the ROS‐mediated NF‐κB signaling pathway in vitro and in vivo. Inflammation. 2020; 43(3): 810‐ 820. 10.1007/s10753-019-01167-y 31897918 · DOI
  41. [42]Yang Z, Liu M, Wang W, et al. Pseudolaric acid B attenuates atopic dermatitis‐like skin lesions by inhibiting interleukin‐17‐induced inflammation. Sci Rep. 2017; 7(1): 7918. 10.1038/s41598-017-08485-x 28801611 PMC5554149 · DOI
  42. [43]Liu B, Zhang M, Zhao J, Zheng M, Yang H. Imbalance of M1/M2 macrophages is linked to severity level of knee osteoarthritis. Exp Ther Med. 2018; 16(6): 5009‐ 5014. 10.3892/etm.2018.6852 30546406 PMC6256852 · DOI
  43. [44]Zhou F, Mei J, Yang S, et al. Modified ZIF‐8 nanoparticles attenuate osteoarthritis by reprogramming the metabolic pathway of synovial macrophages. ACS Appl Mater Interfaces. 2020; 12(2): 2009‐ 2022. 10.1021/acsami.9b16327 31849213 · DOI
  44. [45]Dyke JP, Aaron RK. Noninvasive methods of measuring bone blood perfusion. Ann N Y Acad Sci. 2010; 1192: 95‐ 102. 10.1111/j.1749-6632.2009.05376.x 20392223 PMC2894463 · DOI
  45. [46]Henrotin Y, Pesesse L, Lambert C. Targeting the synovial angiogenesis as a novel treatment approach to osteoarthritis. Ther Adv Musculoskelet Dis. 2014; 6(1): 20‐ 34. 10.1177/1759720X13514669 24489612 PMC3897168 · DOI
  46. [47]MacDonald IJ, Liu SC, Su CM, Wang YH, Tsai CH, Tang CH. Implications of angiogenesis involvement in arthritis. Int J Mol Sci. 2018; 19(7): 2012. 10.3390/ijms19072012 PMC6073145 29996499 · DOI
  47. [48]Peng Y, Wu S, Li Y, Crane JL. Type H blood vessels in bone modeling and remodeling. Theranostics. 2020; 10(1): 426‐ 436. 10.7150/thno.34126 31903130 PMC6929606 · DOI
  48. [49]Limagne E, Lancon A, Delmas D, Cherkaoui‐Malki M, Latruffe N. Resveratrol interferes with IL1‐beta‐induced pro‐inflammatory paracrine interaction between primary chondrocytes and macrophages. Nutrients. 2016; 8(5). 10.3390/nu8050280 PMC4882693 27187448 · DOI
  49. [50]Moon SM, Lee SA, Han SH, et al. Aqueous extract of Codium fragile alleviates osteoarthritis through the MAPK/NF‐kappaB pathways in IL‐1beta‐induced rat primary chondrocytes and a rat osteoarthritis model. Biomed Pharmacother. 2018; 97: 264‐ 270. 29091874
  50. [51]Ran J, Ma C, Xu K, et al. Schisandrin B ameliorated chondrocytes inflammation and osteoarthritis via suppression of NF‐kappaB and MAPK signal pathways. Drug Des Devel Ther. 2018; 12: 1195‐ 1204. 10.2147/dddt.S162014 PMC5953308 29785089 · DOI
  51. [52]Chen C, Zhang C, Cai L, et al. Baicalin suppresses IL‐1beta‐induced expression of inflammatory cytokines via blocking NF‐kappaB in human osteoarthritis chondrocytes and shows protective effect in mice osteoarthritis models [Journal Article]. Int Immunopharmacol. 2017; 52: 218‐ 226. 10.1016/j.intimp.2017.09.017 28942223 · DOI
  52. [53]Fan H, Wu Q, Peng L, et al. Phyllolobium chinense Fisch Flavonoids (PCFF) Suppresses the M1 Polarization of LPS‐Stimulated RAW264.7 Macrophages by Inhibiting NF‐kappaB/iNOS Signaling Pathway. Front Pharmacol. 2020; 11: 864. 10.3389/fphar.2020.00864 32625088 PMC7314944 · DOI
  53. [54]Zhu X, Chen F, Lu K, Wei A, Jiang Q, Cao W. PPARgamma preservation via promoter demethylation alleviates osteoarthritis in mice. Ann Rheum Dis. 2019; 78(10): 1420‐ 1429. 10.1136/annrheumdis-2018-214940 31239244 · DOI
  54. [55]Vasheghani F, Zhang Y, Li YH, et al. PPARgamma deficiency results in severe, accelerated osteoarthritis associated with aberrant mTOR signalling in the articular cartilage. Ann Rheum Dis. 2015; 74(3): 569‐ 578. 10.1136/annrheumdis-2014-205743 25573665 PMC4345902 · DOI · Paper page
  55. [56]Zhou F, Mei J, Han X, et al. Kinsenoside attenuates osteoarthritis by repolarizing macrophages through inactivating NF‐κB/MAPK signaling and protecting chondrocytes. Acta Pharmaceutica Sinica B. 2019; 9(5): 973‐ 985. 10.1016/j.apsb.2019.01.015 31649847 PMC6804452 · DOI · Paper page

Cited by

Sorted by citations

Authors
Lu, J., Guan, H., Wu, D., Hu, Z., Zhang, H., Jiang, H., Yu, J., Zeng, K., Li, H., Zhang, H., Pan, C., Cai, D., & Yu, X.
Affiliations
  • Third Affiliated Hospital of Southern Medical University (CN)
  • Southern Medical University (CN)
  • Gannan Medical University (CN)
Corresponding author
  • Pan, Chenglong
  • Cai, Daozhang
  • Yu, Xiao
Venue
Journal of Cellular and Molecular Medicine
Publisher
Wiley
Published
2021-06-11
Volume
25
Issue
14
Pages
6664-6678
ISSN
  • 1582-1838 (ISSN-L)
  • 1582-4934
OpenAlex
W3169455671
Cited by
24
References
1
Citations by year
2026: 3 · 2025: 5 · 2024: 7 · 2023: 6 · 2022: 2 · 2021: 1
FWCI
3.01
Type
journal article
Language
en
Open access
Locations
  • Journal of Cellular and Molecular Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China (81902229, 81772406, 81974341, 81801579)
Topics
  • Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
  • Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Keywords
pseudolaric acid B, osteoarthritis, synovitis, M1 macrophages, angiogenesis, NF-κB signaling, inflammatory cytokines, articular cartilage degeneration, diterpene acids, anti-inflammatory therapy
MeSH terms
RAW 264.7 Cells, Animals, Blood Vessels, Cartilage, Articular, Disease Models, Animal, Diterpenes, Humans, Inflammation, Osteoarthritis, Synovitis, Signal Transduction, NF-kappa B, Chondrocytes, PPAR gamma, Mice, Transcription Factor RelA

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review